View Diabetes Astrazeneca Products Background. John yee of astrazeneca discusses the 86 abstracts that showcase clinical data from multiple approved products at the american diabetes association 2015. Astrazeneca's (azn) farxiga led to a statistical significant reduction in hospitalization for heart failure or cv astrazeneca plc.
B8bweypncmiflm from scx2.b-cdn.net
The medication was given the green light. Approval for a new diabetes treatment that combines two of its existing drugs after regulators asked for additional data that may require new clinical trials. Diabetes is a growing disease and an enormous global burden that is projected to affect more than 592 million people by 2035.
Astrazeneca's deep pipeline of medicines focusing on their key therapeutic areas.
You may report side effects related to astrazeneca products by clicking here. Astrazeneca notes that the eu submission for qtern included data from three studies in type 2 diabetes and that, in these trials, the safety profile of the combination was similar to the known safety. John yee of astrazeneca discusses the 86 abstracts that showcase clinical data from multiple approved products at the american diabetes association 2015. Astrazeneca's deep pipeline of medicines focusing on their key therapeutic areas.
